Structure−Activity Relationships of a Series of Substituted Benzamides: Potent D<sub>2</sub>/5-HT<sub>2</sub> Antagonists and 5-HT<sub>1a</sub> Agonists as Neuroleptic Agents
作者:Mark H. Norman、Greg C. Rigdon、William R. Hall、Frank Navas
DOI:10.1021/jm950551d
日期:1996.1.1
A series of substituted (4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)benzamide derivatives was prepared and evaluated as potential atypical antipsychotic agents. The target compounds were readily prepared from their benzoyl chloride, benzoic acid, or isatoic anhydride precursors, and they were evaluated in vitro for their ability to bind to dopamine D2, serotonin 5-HT2, and serotonin 5-HT1a
制备了一系列取代的(4-(4-(1,2-苯并噻唑-3-基)-1-哌嗪基)丁基)苯甲酰胺衍生物,并将其评估为潜在的非典型抗精神病药。目标化合物可以很容易地从其苯甲酰氯,苯甲酸或等位酸酐的前体制备,并在体外评估它们与多巴胺D2、5-羟色胺5-HT2和5-羟色胺5-HT1a受体结合的能力。为了评估这些化合物的潜在抗精神病活性,我们研究了它们在小鼠中抑制阿扑吗啡诱导的爬升反应的能力。进一步评估了选定的化合物,以确定其潜在的副作用。本文讨论了单取代的和多取代的苯甲酰胺的结构-活性关系。尽管几种类似物在体外和体内具有潜在的非典型抗精神病药活性,但蒽环酰胺77(1192U90)的药理作用却十分出色。这项研究的结果是,选择1192U90(2-氨基-N-(4-(4-(1,2-苯并噻唑-3-基)-1-哌嗪基)丁基)苯甲酰胺盐酸盐进行进一步评估。目前正在I期临床试验中,作为一种潜在的非典型抗精神病药。